HIV vaccine nears clinical trial following new findings

(Oregon Health& Science University) A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version of the vaccine has been shown to provide similar protection as its original version. The vaccine -- which uses a form of the common herpes virus cytomegalovirus, or CMV -- was live-attenuated, or weakened so CMV couldn't spread as easily. Having an attenuated version of the vaccine is key to being potentially able to use it in humans.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news